Discovery of Natural Proteasome Inhibitors as Novel Anticancer Therapeutics: Current Status and Perspectives

E-ISSN： 1875-5550|19|4|358-367

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.19, Iss.4, 2018-02, pp. : 358-367

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial; Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery – Part II

Current Protein and Peptide Science, Vol. 19, Iss. 4, 2018-02 ,pp. : 342-342

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: Natural Product Inhibitors of Enzymatic Targets in Anticancer Drug Discovery – Part I

Current Protein and Peptide Science, Vol. 19, Iss. 3, 2018-01 ,pp. : 236-237

Bentham Science Publishers

Access to resources Recommend Favorite

Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery

Current Protein and Peptide Science, Vol. 19, Iss. 3, 2018-01 ,pp. : 292-301

Bentham Science Publishers

Access to resources Recommend Favorite

Bowman-Birk Inhibitors from Legumes and Human Gastrointestinal Health: Current Status and Perspectives

Current Protein and Peptide Science, Vol. 12, Iss. 5, 2011-08 ,pp. : 358-373

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of novel PTP1b inhibitors

By Ockey D.A. Gadek T.R.

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 2, 2004-01 ,pp. : 389-391

Elsevier

Access to resources Recommend Favorite